ARS Pharmaceuticals's Earnings: A Preview

ARS Pharmaceuticals SPRY is set to give its latest quarterly earnings report on Wednesday, 2025-05-14. Here's what investors need to know before the announcement.

Analysts estimate that ARS Pharmaceuticals will report an earnings per share (EPS) of $-0.36.

The announcement from ARS Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Performance in Previous Earnings

During the last quarter, the company reported an EPS beat by $0.60, leading to a 13.63% drop in the share price on the subsequent day.

Here's a look at ARS Pharmaceuticals's past performance and the resulting price change:

Stock Performance

Shares of ARS Pharmaceuticals were trading at $13.29 as of May 12. Over the last 52-week period, shares are up 47.07%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for ARS Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.